Literature DB >> 17571163

TRAIL limits excessive host immune responses in bacterial meningitis.

Olaf Hoffmann1, Josef Priller, Timour Prozorovski, Ulf Schulze-Topphoff, Nevena Baeva, Jan D Lunemann, Orhan Aktas, Cordula Mahrhofer, Sarah Stricker, Frauke Zipp, Joerg R Weber.   

Abstract

Apart from potential roles in anti-tumor surveillance, the TNF-related apoptosis-inducing ligand (TRAIL) has important regulatory functions in the host immune response. We studied antiinflammatory effects of endogenous and recombinant TRAIL (rTRAIL) in experimental meningitis. Following intrathecal application of pneumococcal cell wall, a TLR2 ligand, we found prolonged inflammation, augmented clinical impairment, and increased apoptosis in the hippocampus of TRAIL(-/-) mice. Administration of rTRAIL into the subarachnoid space of TRAIL(-/-) mice or reconstitution of hematopoiesis with wild-type bone marrow cells reversed these effects, suggesting an autoregulatory role of TRAIL within the infiltrating leukocyte population. Importantly, intrathecal application of rTRAIL in wild-type mice with meningitis also decreased inflammation and apoptosis. Moreover, patients suffering from bacterial meningitis showed increased intrathecal synthesis of TRAIL. Our findings provide what we believe is the first evidence that TRAIL may act as a negative regulator of acute CNS inflammation. The ability of TRAIL to modify inflammatory responses and to reduce neuronal cell death in meningitis suggests that it may be used as a novel antiinflammatory agent in invasive infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17571163      PMCID: PMC1888568          DOI: 10.1172/JCI30356

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  55 in total

1.  Apoptosis-inducing factor mediates microglial and neuronal apoptosis caused by pneumococcus.

Authors:  J S Braun; R Novak; P J Murray; C M Eischen; S A Susin; G Kroemer; A Halle; J R Weber; E I Tuomanen; J L Cleveland
Journal:  J Infect Dis       Date:  2001-10-15       Impact factor: 5.226

2.  Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)

Authors:  R Nitsch; I Bechmann; R A Deisz; D Haas; T N Lehmann; U Wendling; F Zipp
Journal:  Lancet       Date:  2000-09-02       Impact factor: 79.321

Review 3.  Bacterial meningitis: pathogenesis, pathophysiology, and progress.

Authors:  V Quagliarello; W M Scheld
Journal:  N Engl J Med       Date:  1992-09-17       Impact factor: 91.245

4.  Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators.

Authors:  A Lee; M K Whyte; C Haslett
Journal:  J Leukoc Biol       Date:  1993-10       Impact factor: 4.962

5.  Sequelae from bacterial meningitis and their relation to the clinical condition during acute illness, based on 667 questionnaire returns. Part II of a three part series.

Authors:  V Bohr; B Hansen; H Kjersem; N Rasmussen; N Johnsen; H S Kristensen; O Jessen
Journal:  J Infect       Date:  1983-09       Impact factor: 6.072

6.  Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis.

Authors:  S L Leib; J M Clements; R L Lindberg; C Heimgartner; J M Loeffler; L A Pfister; M G Täuber; D Leppert
Journal:  Brain       Date:  2001-09       Impact factor: 13.501

7.  Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis.

Authors:  B Hilliard; A Wilmen; C Seidel; T S Liu; R Göke; Y Chen
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

8.  Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l.

Authors:  J J Lum; A A Pilon; J Sanchez-Dardon; B N Phenix; J E Kim; J Mihowich; K Jamison; N Hawley-Foss; D H Lynch; A D Badley
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Evaluation of vancomycin for therapy of adult pneumococcal meningitis.

Authors:  P F Viladrich; F Gudiol; J Liñares; R Pallarés; I Sabaté; G Rufí; J Ariza
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

10.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression.

Authors:  K Song; Y Chen; R Göke; A Wilmen; C Seidel; A Göke; B Hilliard; Y Chen
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

View more
  26 in total

1.  Bacterial pore-forming cytolysins induce neuronal damage in a rat model of neonatal meningitis.

Authors:  Anja Reiss; Johann S Braun; Katja Jäger; Dorette Freyer; Gregor Laube; Christoph Bührer; Ursula Felderhoff-Müser; Christine Stadelmann; Victor Nizet; Joerg R Weber
Journal:  J Infect Dis       Date:  2010-12-24       Impact factor: 5.226

2.  Pathophysiology and treatment of bacterial meningitis.

Authors:  Olaf Hoffman; R Joerg Weber
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

3.  Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system.

Authors:  Ulf Schulze-Topphoff; Alexandre Prat; Timour Prozorovski; Volker Siffrin; Magdalena Paterka; Josephine Herz; Ivo Bendix; Igal Ifergan; Ines Schadock; Marcelo A Mori; Jack Van Horssen; Friederike Schröter; Alina Smorodchenko; May Htwe Han; Michael Bader; Lawrence Steinman; Orhan Aktas; Frauke Zipp
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

4.  Tumor necrosis factor-related apoptosis-inducing ligand mediates the resolution of allergic airway inflammation induced by chronic allergen inhalation.

Authors:  L Faustino; D M Fonseca; E B Florsheim; R R Resende; A P Lepique; E Faquim-Mauro; E Gomes; J S Silva; H Yagita; M Russo
Journal:  Mucosal Immunol       Date:  2014-02-26       Impact factor: 7.313

5.  Lymphocytes modulate innate immune responses and neuronal damage in experimental meningitis.

Authors:  Olaf Hoffmann; Olga Rung; Josephin Held; Chotima Boettcher; Stefan Prokop; Werner Stenzel; Josef Priller
Journal:  Infect Immun       Date:  2014-10-27       Impact factor: 3.441

Review 6.  Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation.

Authors:  Olaf Hoffmann; Frauke Zipp; Joerg R Weber
Journal:  J Mol Med (Berl)       Date:  2009-05-17       Impact factor: 4.599

7.  Soluble TRAIL in normal pregnancy and acute pyelonephritis: a potential explanation for the susceptibility of pregnant women to microbial products and infection.

Authors:  Piya Chaemsaithong; Roberto Romero; Steven J Korzeniewski; Alyse G Schwartz; Tamara Stampalija; Zhong Dong; Lami Yeo; Edgar Hernandez-Andrade; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-04-22

8.  CD8+ T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons.

Authors:  Bimmi Shrestha; Amelia K Pinto; Sharone Green; Irene Bosch; Michael S Diamond
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

Review 9.  Distinct roles of TNF-related apoptosis-inducing ligand (TRAIL) in viral and bacterial infections: from pathogenesis to pathogen clearance.

Authors:  Valeriya Gyurkovska; Nina Ivanovska
Journal:  Inflamm Res       Date:  2016-03-04       Impact factor: 4.575

Review 10.  Following TRAIL's path in the immune system.

Authors:  Christina Falschlehner; Uta Schaefer; Henning Walczak
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.